We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Biochemical Signals Guide Intestinal Pathogens

By Biotechdaily staff writers
Posted on 18 Jul 2003
Researchers have found that Escherichia coli O157:H7, an intestinal pathogen that produces large quantities of one or more potent toxins that cause severe damage to the lining of the intestine, responds to biochemical signals transmitted by bacteria of the intestinal flora as well as hormones from intestinal cells in order to locate sites of attachment--a prelude to activation of toxin-producing genes.


The inter-bacterial communication system known as quorum sensing (QS) utilizes hormone-like compounds referred to as autoinducers to regulate bacterial gene expression. More...
The QS system used by O157:H7 is the LuxS/autoinducer 2 (AI-2) system extensively involved in interspecies communication. The autoinducer AI-2 is a furanosyl borate diester whose synthesis depends on the enzyme LuxS.


In the current study, published July 7, 2003, in the online edition of the Proceedings of the National Academy of Sciences, investigators at the University of Texas Southwestern Medical Center (Dallas) showed that an O157:H7 luxS mutant, unable to produce the bacterial autoinducer, still responded to a eukaryotic cell signal to activate expression of its virulence genes. They identified this signal as the hormone epinephrine and showed that beta- and alpha-adrenergic antagonists blocked the bacterial response to this hormone.

The authors speculated that their study could lead to the development of beta blockers as a therapy to impede this cellular signaling system, causing the harmful bacteria to pass blindly through the digestive tract. "You are not really attacking the bacteria per se,” explained first author Dr. Vanessa Sperandio, assistant professor of microbiology at the University of Texas Southwestern Medical Center. "You are just rendering it blind. The bacteria will not activate the virulent genes unless it knows where it is. If it cannot activate the things it needs to bind to the intestine, it will be washed away.”




Related Links:
University of Texas Southwestern Medical Center

New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Rapid Sepsis Test
SeptiCyte RAPID
New
Multi-Chamber Washer-Disinfector
WD 390
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The device contains specific antibodies that capture the primary biomarker of pancreatic cancer. The binding of these antibodies alters the distribution of electrical charges on the electrode surface. The sensor then translates this variation into a measurable capacitance signal (photo courtesy of Gabriella Soares / IFSC-USP)

Rapid Biosensor Detects Pancreatic Cancer Biomarker for Early Detection

Pancreatic cancer is frequently identified only after it has progressed because early disease is typically asymptomatic, and survival remains extremely poor once advanced. Conventional laboratory assays... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.